KYNTRA BIO, INC.
Ticker: 921299
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
1.76
+219.7%+63.0%
Expenditure
14.63
-9.1%+125.4%
Net Profit
0.16
-98.7%-99.9%
OPM %
-100.00%
-200.00pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingKYNB
20261Oct
Board Meeting
Andrew E. Singer appointed as independent director and membe…
SEC Filing ↗ Board MeetingKYNB
202612Jun
Board Meeting
Annual meeting of stockholders held to elect a Class III dir…
SEC Filing ↗